gene dosage modulates development of the ganglion, its associated nerves and leads to corneal abnormalities.
that the ophthalmic branch (opV) is present. However, in the absence of any eyes in the homozygous mutants, it projects solely to the eyelids. On the other hand, the maxillary branch (Mx) is abnormal, with reduced arborisation. In particular, the whisker follicles, the major target of the Mx division, seem to be abnormally innervated in Pax6À/À mice with defects in the encirclement of the axons around the follicles. These findings confirmed the association between changes in Pax6 gene dosage and axonal pathfinding, as has already been described for other discrete neuronal populations. Moreover, the downregulated expression in Pax6À/À mice of two neuronal markers, TrkC and Ngn2, suggests defects in the specification of neurones, confirming the role of Pax6 in trigeminal precursor specification. For this purpose, we developed a simple and robust wounding assay which consists of laser wounding 50-80 isogenic Drosophila embryos and looking for unclosed wounds $16 h later.
We have validated our wounding assay in a pilot screen using mutations previously described to affect either wound or dorsal closure in the fly. We found that a mutant in the JNK signaling pathway showed wound closure defects in our assay, in accordance with previous work showing the requirement for this signaling pathway on larval wound healing.
In our primary screen we tested 655 insertional mutant lines available from public databases and found that 30 of these mutants consistently showed over 30% of unclosed wounds in our assay.
Using this methodology, we have isolated a group of novel 'wound healing genes' containing not only expected genes, like known cytoskeleton regulators, but also some unanticipated as well as completely unstudied genes. The involvement of one such candidate currently under study will be discussed. At this purpose, we have constructed a GFP-fusion protein with S91
